Vivelle-Dot vs. Bijuva
See how Vivelle-Dot and Bijuva compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Vivelle-Dot is an estrogen-only patch changed twice a week, while Bijuva is a combined estrogen-progesterone capsule swallowed once a day.
Vivelle-Dot has extra FDA approvals for vaginal atrophy, ovarian failure, and osteoporosis prevention that Bijuva does not carry.
Because Bijuva already contains progesterone, it protects the uterine lining without needing a second prescription for women who have a uterus.
Vivelle-Dot vs. Bijuva Drug Summary
Vivelle-Dot
Vivelle-Dot is an estrogen-only hormone therapy patch containing estradiol. It treats hot flashes, vaginal dryness from menopause, and low estrogen from ovarian failure, and can help prevent postmenopausal bone loss. It's applied to the abdomen or buttocks and replaced twice weekly.
Bijuva
Bijuva is a combination hormone therapy capsule containing bioidentical estradiol and progesterone. It treats moderate to severe hot flashes in menopausal women who still have a uterus, delivering both hormones together in one capsule. It's swallowed once daily, ideally with food to boost absorption.
Vivelle-Dot vs. Bijuva Side Effects
Vivelle-Dot
Bijuva
Vivelle-Dot vs. Bijuva Dosage
Vivelle-Dot
Bijuva
| STAGE | DOSE | WHEN |
| Starting dose | 0.0375 mg/day patch | At the start |
| Maximum dose | 0.025 mg/day patch | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Vivelle-Dot
| STAGE | DOSE | WHEN |
| Starting dose | 0.0375 mg/day patch | At the start |
| Maximum dose | 0.025 mg/day patch | If needed |
| Dose changes | 2 increases | As tolerated |
Bijuva
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Vivelle-Dot vs. Bijuva Indications
Vivelle-Dot
Vivelle-Dot is FDA-approved for several menopause-related conditions beyond hot flashes. It also treats vaginal atrophy, replaces estrogen lost to ovarian failure or removal, and helps prevent bone loss after menopause when other options aren't suitable.
Moderate to severe hot flashes and night sweats from menopause
Moderate to severe vaginal dryness and irritation from menopause
Low estrogen from ovarian failure, removal, or hypogonadism
Prevention of postmenopausal osteoporosis when other options aren't suitable
Bijuva
Bijuva is FDA-approved for one specific use: moderate to severe hot flashes from menopause. It's built only for women who still have a uterus, since its progesterone component protects the uterine lining from unopposed estrogen.
Moderate to severe hot flashes and night sweats from menopause
Approved specifically for women who still have a uterus
Combines estrogen and progesterone in one daily capsule
Not approved for osteoporosis prevention or vaginal atrophy alone
Vivelle-Dot vs. Bijuva Pros and Cons
Vivelle-Dot
Vivelle-Dot delivers estrogen through the skin, avoiding the liver metabolism that oral estrogens go through, and it comes in five dose strengths for fine-tuning. Because it doesn't contain progesterone, women with a uterus need to add a separate progestin. Coverage varies by plan, and ongoing shortages have made both brand and generic patches harder to find at times.
Pros
Transdermal delivery skips first-pass liver metabolism, unlike oral hormones
Five dose strengths (0.025 to 0.1 mg/day) allow precise titration
Also approved for vaginal atrophy, ovarian failure, and osteoporosis prevention
Generic estradiol patches exist, often $30 to $80 a month without insurance
Cons
Requires a separate progestin prescription for women with a uterus
Patch can cause skin redness, irritation, or detachment at the site
Brand-name and generic patches have faced ongoing supply shortages
Bijuva
Bijuva pairs bioidentical estradiol with bioidentical progesterone in a single capsule, so women with a uterus don't need a second prescription for endometrial protection. It's approved only for hot flashes, without the broader menopause indications Vivelle-Dot carries. There's no generic version, and absorption depends on taking it consistently with food.
Pros
Combines bioidentical estradiol and progesterone in one daily capsule
Already protects the uterine lining, no separate progestin needed
Only FDA-approved product pairing bioidentical estradiol with progesterone
No patch, so no adhesive or skin site issues
Cons
Only approved for hot flashes, not vaginal atrophy or osteoporosis prevention
Cannot be used in women without a uterus
No generic version, brand-only pricing runs roughly $257 to $351 a month
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.